Menu

Blog

Page 2446

Apr 11, 2023

Exploring the Global Clinical and Preclinical Antibacterial Pipelines

Posted by in categories: biotech/medical, genetics

What is antibiotic resistance? What is the global clinical antibacterial pipeline? What is the global preclinical antibacterial pipeline? Institutions associated with preclinical drug development Preclinical projects Trends in the preclinical antibacterial pipeline References Further reading.

The global preclinical antibacterial pipeline refers to innovative antibacterial candidate drugs that are under development with the aim of effectively eliminating newly emerged and pre-existing priority pathogens.

Antibacterial medicines or antibiotics treat bacterial infections in humans, animals, and plants. However, bacteria may eventually develop resistance against antibiotics-mediated killing by acquiring genetic mutations. Although antibiotic resistance occurs naturally, misuse or overuse of antibiotics can significantly escalate the process.

Apr 11, 2023

Dietary supplement helps combat resistance in breast cancer, finds study

Posted by in categories: biotech/medical, genetics

Many cancer therapies do not produce the hoped-for results. A common reason for this is that the tumors develop resistance to the medications. This is the case, for example, with alpelisib, a drug that has been approved for use in Switzerland for the past few years as a treatment for advanced breast cancer.

A research group at the Department of Biomedicine of the University of Basel has now discovered that the loss of the neurofibromin 1 (NF1) gene leads to a reduced response to alpelisib. The researchers also found that the dietary supplement N-acetylcysteine restores the sensitivity of cancer cells to this treatment. The findings have been published in the journal Cell Reports Medicine on April 11.

At the moment, patients with advanced and metastatic breast cancer lack effective treatment options. The PI3K signaling pathway is often overactive in breast cancer due to mutations promoting tumor development. The approval of the PI3K inhibitor Alpelisib was therefore keenly anticipated.

Apr 11, 2023

JUST REVEALED! Best Performing Japanese Humanoid Robots | Artificial Intelligence News

Posted by in categories: innovation, robotics/AI

Most Beautiful japanese humanoid Robots | AI SCience |

The world of robots is evolving at an unprecedented rate. We just cannot imagine the kind of innovations the Japanese companies have come up with when it comes to humanoid robots. There are a lot of new technological upgrades in these robots that will prove to be very important as time passes. But what possible capabilities can we reach through it? Stay tuned and you shall find all of the answers.
#WhatisArtificialIntelligence #QuickSupport #Innovation.

Continue reading “JUST REVEALED! Best Performing Japanese Humanoid Robots | Artificial Intelligence News” »

Apr 11, 2023

Bio-Inspired Quantum Technologies

Posted by in categories: biological, computing, quantum physics

The Oxford Martin Programme on Bio-Inspired Technologies is investigating the possibility of making computers real.

We aim to develop a completely new methodology for overcoming the extreme fragility of memory. By learning how biological molecules shield fragile states from the environment, we hope to create the building blocks of future computers.

The unique power of computers comes from their ability to carry out all possible calculations in parallel.

Apr 11, 2023

Multiscale quantum algorithms for quantum chemistry

Posted by in categories: chemistry, computing, information science, quantum physics

As quantum advantage has been demonstrated on different quantum computing platforms using Gaussian boson sampling,1–3 quantum computing is moving to the next stage, namely demonstrating quantum advantage in solving practical problems. Two typical problems of this kind are computational-aided material design and drug discovery, in which quantum chemistry plays a critical role in answering questions such as ∼Which one is the best?∼. Many recent efforts have been devoted to the development of advanced quantum algorithms for solving quantum chemistry problems on noisy intermediate-scale quantum (NISQ) devices,2,4–14 while implementing these algorithms for complex problems is limited by available qubit counts, coherence time and gate fidelity. Specifically, without error correction, quantum simulations of quantum chemistry are viable only if low-depth quantum algorithms are implemented to suppress the total error rate. Recent advances in error mitigation techniques enable us to model many-electron problems with a dozen qubits and tens of circuit depths on NISQ devices,9 while such circuit sizes and depths are still a long way from practical applications.

The difference between the available and actually required quantum resources in practical quantum simulations has renewed the interest in divide and conquer (DC) based methods.15–19 Realistic material and (bio)chemistry systems often involve complex environments, such as surfaces and interfaces. To model these systems, the Schrödinger equations are much too complicated to be solvable. It therefore becomes desirable that approximate practical methods of applying quantum mechanics be developed.20 One popular scheme is to divide the complex problem under consideration into as many parts as possible until these become simple enough for an adequate solution, namely the philosophy of DC.21 The DC method is particularly suitable for NISQ devices since the sub-problem for each part can in principle be solved with fewer computational resources.15–18,22–25 One successful application of DC is to estimate the ground-state potential energy surface of a ring containing 10 hydrogen atoms using the density matrix embedding theory (DMET) on a trapped-ion quantum computer, in which a 20-qubit problem is decomposed into ten 2-qubit problems.18

DC often treats all subsystems at the same computational level and estimates physical observables by summing up the corresponding quantities of subsystems, while in practical simulations of complex systems, the particle–particle interactions may exhibit completely different characteristics in and between subsystems. Long-range Coulomb interactions can be well approximated as quasiclassical electrostatic interactions since empirical methods, such as empirical force filed (EFF) approaches,26 are promising to describe these interactions. As the distance between particles decreases, the repulsive exchange interactions from electrons having the same spin become important so that quantum mean-field approaches, such as Hartree–Fock (HF), are necessary to characterize these electronic interactions.

Apr 11, 2023

Amazon Looks to Grow Diamonds in Bid to Boost Computer Networks

Posted by in categories: computing, quantum physics

Quantum networking uses subatomic matter to deliver data in a way that goes beyond today’s fiber-optic systems. Amazon wants to grow diamonds which would be part of a component that lets the data travel farther without breaking down.

Pretty futuristic!


Amazon.com Inc. is teaming up with a unit of De Beers Group to grow artificial diamonds, betting that custom-made gems could could help revolutionize computer networks.

Continue reading “Amazon Looks to Grow Diamonds in Bid to Boost Computer Networks” »

Apr 11, 2023

Beyond DNA and RNA: The Expanding Toolbox of Synthetic Genetics

Posted by in categories: bioengineering, biotech/medical, chemistry, evolution, genetics, nanotechnology

The remarkable physicochemical properties of the natural nucleic acids, DNA and RNA, define modern biology at the molecular level and are widely believed to have been central to life’s origins. However, their ability to form repositories of information as well as functional structures such as ligands (aptamers) and catalysts (ribozymes/DNAzymes) is not unique. A range of nonnatural alternatives, collectively termed xeno nucleic acids (XNAs), are also capable of supporting genetic information storage and propagation as well as evolution. This gives rise to a new field of “synthetic genetics,” which seeks to expand the nucleic acid chemical toolbox for applications in both biotechnology and molecular medicine. In this review, we outline XNA polymerase and reverse transcriptase engineering as a key enabling technology and summarize the application of “synthetic genetics” to the development of aptamers, enzymes, and nanostructures.

Copyright © 2019 Cold Spring Harbor Laboratory Press; all rights reserved.

Apr 11, 2023

Evolution. Toward an alternative biology

Posted by in categories: biological, evolution

NCBI Literature Resources.

MeSH PMC Bookshelf Disclaimer.

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

Apr 11, 2023

Macromolecular Information Transfer

Posted by in categories: biotech/medical, computing

Macromolecular information transfer can be defined as the process by which a coded monomer sequence is communicated from one macromolecule to another. In such a transfer process, the information sequence can be kept identical, transformed into a complementary sequence or even translated into a different molecular language. Such mechanisms are crucial in biology and take place in DNA→DNA replication, DNA→RNA transcription and RNA→protein translation. In fact, there would be no life on Earth without macromolecular information transfer. Mimicking such processes with synthetic macromolecules would also be of major scientific relevance because it would open up new avenues for technological applications (e.g. data storage and processing) but also for the creation of artificial life. In this important context, this minireview summarizes recent research about information transfer in synthetic oligomers and polymers. Medium-and long-term perspectives are also discussed.

Keywords: Artificial Translation; Molecular Replication; Precision Polymers; Sequence-Controlled Polymers; Template-Directed Synthesis.

© 2023 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.

Apr 11, 2023

The origin of life: RNA and protein co-evolution on the ancient Earth

Posted by in categories: biotech/medical, chemistry, evolution, genetics

How life emerged from simple non-life chemicals on the ancient Earth is one of the greatest mysteries in biology. The gene expression system of extant life is based on the interdependence between multiple molecular species (DNA, RNA, and proteins). While DNA is mainly used as genetic material and proteins as functional molecules in modern biology, RNA serves as both genetic material and enzymes (ribozymes). Thus, the evolution of life may have begun with the birth of a ribozyme that replicated itself (the RNA world hypothesis), and proteins and DNA joined later. However, the complete self-replication of ribozymes from monomeric substrates has not yet been demonstrated experimentally, due to their limited activity and stability. In contrast, peptides are more chemically stable and are considered to have existed on the ancient Earth, leading to the hypothesis of RNA-peptide co-evolution from the very beginning. Our group and collaborators recently demonstrated that peptides with both hydrophobic and cationic moieties (e.g., KKVVVVVV) form β-amyloid aggregates that adsorb RNA and enhance RNA synthesis by an artificial RNA polymerase ribozyme and a simple peptide with only seven amino acid types (especially rich in valine and lysine) can fold into the ancient β-barrel conserved in various enzymes, including the core of cellular RNA polymerases. These findings, together with recent reports from other groups, suggest that simple prebiotic peptides could have supported the ancient RNA-based replication system, gradually folded into RNA-binding proteins, and eventually evolved into complex proteins like RNA polymerase.

Keywords: RNA world; ancient proteins; central dogma; origin of life; peptide.

© 2023 Japanese Society of Developmental Biologists.